# Cisatracurium Besylate

NDC: 31722-313
Generic name: Cisatracurium Besylate
Labeler / Manufacturer: Camber Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260504

FDA application: ANDA212432

## Active ingredients

- CISATRACURIUM BESYLATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-313"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-313
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8b5eb77-b393-4cd7-86c5-d2a9d131f96d